We are live on ! Find out more
TCM

Timpani Capital Management Portfolio holdings

AUM $209M
1-Year Est. Return 62.15%
This Fund
S&P 500
This Quarter Est. Return
+31.41%
1 Year Est. Return
+62.15%
3 Year Est. Return
+383.19%
5 Year Est. Return
+934.71%
10 Year Est. Return
–
AUM
$209M
AUM Growth
+$30.9M
Cap. Flow
-$4.66M
Cap. Flow %
-2.23%
Top 10 Hldgs %
25.2%
Holding
119
New
33
Increased
22
Reduced
36
Closed
28

Top Buys

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$3.9M
2
TREE icon
LendingTree
TREE
+$3.51M
3
WK icon
Workiva
WK
+$3.45M
4
GKOS icon
Glaukos
GKOS
+$2.5M
5
NOVT icon
Novanta
NOVT
+$2.43M

Top Sells

Rank Stock Value
1
GDOT icon
Green Dot
GDOT
+$6.69M
2
LGND icon
Ligand Pharmaceuticals
LGND
+$3.68M
3
GNRC icon
Generac Holdings
GNRC
+$3.44M
4
VRNS icon
Varonis Systems
VRNS
+$2.95M
5
INGN icon
Inogen
INGN
+$2.68M

Sector Composition

Rank Sector Weight
1 Technology 31.48%
2 Healthcare 24.62%
3 Industrials 12.2%
4 Consumer Staples 10.9%
5 Consumer Discretionary 8.29%

No holdings matched the selected filter criteria.

1 2 3 4 5

Similar funds

UIM
Underhill Investment Management Greenbrae, California $189M AUM 5.4% 1-Year Est. Return
CI
Caerus Investors New York $183M AUM 0.18% 1-Year Est. Return
CWM
Catamount Wealth Management Westport, Connecticut $176M AUM 15.01% 1-Year Est. Return
BA
BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
HAM
Hillswick Asset Management Stamford, Connecticut $150M AUM 7.89% 1-Year Est. Return
EMR
Errol M. Rudman $148M AUM 19.65% 1-Year Est. Return
NAP
New Amsterdam Partners New York $272M AUM 12.21% 1-Year Est. Return

Timpani Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Timpani Capital Management held 119 positions worth $209M, up 17% from $178M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Timpani Capital Management's Q1 2019 filing shows 33 new, 22 increased, 36 reduced and 28 closed positions. Its largest new stake was Array Biopharma Inc: 187,268 shares worth $4.57M. The largest sale was Green Dot, an estimated $6.69M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Timpani Capital Management's largest Q1 2019 buy was Array Biopharma Inc: 187,268 shares worth $4.57M.
  • Timpani Capital Management added most to GDS Holdings in Q1 2019, an estimated $1.52M increase.
  • Timpani Capital Management's biggest Q1 2019 reduction was Canada Goose Holdings, cutting an estimated $2.25M.
  • Timpani Capital Management fully exited Green Dot in Q1 2019, selling an estimated $6.69M.
  • Timpani Capital Management's ten largest holdings make up 25% of its $209M portfolio in Q1 2019.
  • Timpani Capital Management opened 33 new positions and closed 28 in Q1 2019.
  • Timpani Capital Management's portfolio value rose 17% quarter-over-quarter to $209M.

Based on Timpani Capital Management's 13F filing for Q1 2019, filed 10 May 2019.